Home
5450 All Specialties
1421 Arthroplasty
536 Shoulder & Elbow
504 Sports Medicine
499 Spine
492 Trauma
476 Osteoarthritis
476 Physical Therapy & Rehab
291 Foot & Ankle
284 General Orthopaedics
254 Hand & Wrist
79 Metabolic Disorders
69 Pediatric Orthopaedics
48 Cannabis
21 Tumour
OE Plus
7 Ace Reviews
1 OE Recommends
79 OE Originals
69 OrthoPODS
24 OE World Tour NEW
43 Conferences
149 Exclusive Interviews
15 Evidence Series
CME
PeerView
Orthopaedic Surgeon
Primary Care Physician
Physiotherapist
Occupational Therapist
Sports Medicine Specialist
Orthopaedic Resident/Intern
Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Loading...
Search Filters

Date Range

to

Report Types

ALL
RCT
META
ACE Reviews

Condition

Region of the Body

Specialties

See all (14)

Emerging Treatments

OE Recommends Topics

Multimedia

Journal

Conference Series

Evidence Series

We found 2 results matching your search query

Showing 1 - 2 of 2
Read Ace Report

Similar Outcomes and Prognosis between Osteoblastic Cell vs Standard Therapy in Patients with ONFH

Clin Orthop Relat Res. 2020 01-Jun;():. 10.1097/CORR.0000000000001107

RCT General Orthopaedics Appendicular Lower Extremity Hip Bone Femur Autologous Bone Marrow-Derived Mesenchymal Stem Cell Bone Marrow Concentrate Bone Marrow Stem Cell Mesenchymal Stem Cells Osteonecrosis Biologic Biologic - Hide
Read Ace Report

No effect of 1g IV TXA pre-incision on blood loss or functional outcomes in total hip arthroplasty

Advances in orthopedics. 2020 ;():. 10.1155/2020/2943827

RCT Arthroplasty Osteoarthritis Appendicular Lower Extremity Hip Normal Saline Tranexamic Acid (TXA) Antifibrinolytic agent Antifibrinolytic agent Acetabulofemoral Osteonecrosis - Hide
Showing 1 - 2 of 2